Erika Trahan | Investor Relations |
Stan Erck | President and Chief Executive Officer |
John Trizzino | Chief Business Officer and Chief Financial Officer |
Gregory Glenn | President, Research and Development |
Amy Fix | Senior Vice President, Regulatory Affairs |
Kevin DeGeeter | Oppenheimer |
Michael Higgins | Ladenburg Thalmann |
Vernon Bernardino | H.C. Wainwright |
Matthew Lillis | Cantor |
Good day, ladies and gentlemen and welcome to Novavax Second Quarter 2019 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would like to introduce your host for today’s conference, Ms. Erika Trahan, Senior Manager of Investor Relations and Public Relations. Ms.